Quality of Outpatient Care Delivered to Adults in USA

Quality of Outpatient Care Delivered to Adults in USA

This cross-sectional survey study measures changes in outpatient quality and patient experience in the United States from 2002 to 2013 to determine whether efforts to improve outpatient quality have been successful. Three... read more

Drugs Don’t Cut Trastuzumab-Tied Left Ventricular Remodeling

Drugs Don’t Cut Trastuzumab-Tied Left Ventricular Remodeling

The researchers found that the drugs were well tolerated, with no serious adverse events reported. The indexed left ventricular end diastolic volume increased in patients treated with perindopril, bisoprolol, and placebo... read more

Benefits of PCI for STEMI Not Attenuated in Patients With a Cancer History

Benefits of PCI for STEMI Not Attenuated in Patients With a Cancer History

Having a history of cancer does not worsen outcomes for patients with STEMI who undergo primary PCI and should not be a barrier to revascularization and optimal therapy.... read more

Value of Expedited Drug Approvals for Cancer Care

Value of Expedited Drug Approvals for Cancer Care

This study examines potential benefits of cancer drugs approved by the FDA on the basis of surrogate endpoints.... read more

USPSTF: Don’t Screen Asymptomatic Adults for Thyroid Cancer

USPSTF: Don’t Screen Asymptomatic Adults for Thyroid Cancer

After reviewing studies on the benefits and harms of screening and treatment for thyroid cancer, a newly released U.S. Preventive Services Task Force draft statement recommends against screening asymptomatic adults for the... read more

Successfully treating genetically determined autoimmune enteritis

Successfully treating genetically determined autoimmune enteritis

Using targeted immunotherapy, doctors have succeeded in curing a type of autoimmune enteritis caused by a recently discovered genetic mutation.... read more

New Cytokine Approach is Synergistic With Checkpoint Inhibitors

New Cytokine Approach is Synergistic With Checkpoint Inhibitors

Among the new agents currently being explored in clinical trials, NKTR-214 stands out as a new cytokine therapy approach that could show additive benefit when combined with checkpoint inhibitors. ... read more

CDC estimates preventable deaths from 5 leading causes

CDC estimates preventable deaths from 5 leading causes

The federal Centers for Disease Control and Prevention released data naming the five leading causes of death among Americans under age 80 for 2014.... read more

New discovery paves way for pancreatic cancer treatment

New discovery paves way for pancreatic cancer treatment

Patients suffering from pancreatic cancer may soon face better treatment options due to the latest discovery by Dr. Reginald Hill, who's research focuses on drugs that are already approved by the FDA.... read more

Spread of cancer linked to cell metabolism, study shows

Spread of cancer linked to cell metabolism, study shows

Cellular metabolism in white blood cells can be manipulated to prevent the spread of cancer, VIB and KU Leuven researchers suggest in a new study.... read more

Molecular machines generate Nobel award for European researchers

Molecular machines generate Nobel award for European researchers

Three EU-funded researchers have been awarded a share of the 2016 Nobel Prize in Chemistry for developing molecular machines including a tiny lift, artificial muscles and miniscule motors, that are a thousand times thinner... read more

New tool helps measure how costs of care impact cancer patients

New tool helps measure how costs of care impact cancer patients

For many patients, the uncertainty and stress that can come with cancer treatment is compounded by what is now known as "financial toxicity", the anxiety and distress that follow health care and medication expenses, often... read more

Frontline PARP inhibitor shrinks tumors in BRCA-positive breast patients

Frontline PARP inhibitor shrinks tumors in BRCA-positive breast patients

All 13 newly diagnosed breast cancer patients with BRCA mutations had their tumors shrink significantly when treated with a PARP inhibitor ahead of frontline presurgical chemotherapy in a pilot study at The University of... read more